File:Fmicb-11-01818-g001.jpg

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search

Original file(1,800 × 1,230 pixels, file size: 159 KB, MIME type: image/jpeg)

Captions

Schematic structure of SARS-CoV-2.

Captions

Summary[edit]

Description
English: Schematic structure of SARS-CoV-2. The viral structure is primarily formed by the structural proteins such as spike (S), membrane (M), envelope (E), and nucleocapsid (N) proteins. The S, M, and E proteins are all embedded in the viral envelope, a lipid bilayer derived from the host cell membrane. The N protein interacts with the viral RNA in to the core of the virion.
Date
Source

Santos IA, Grosche VR, Bergamini FRG, Sabino-Silva R and Jardim ACG (2020) Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment? Front. Microbiol. 11:1818.

https://doi.org/10.3389/fmicb.2020.01818
Author Igor de Andrade Santos, Victória Riquena Grosche, Fernando Rodrigues Goulart Bergamini, Robinson Sabino-Silva, and Ana Carolina Gomes Jardim

Licensing[edit]

w:en:Creative Commons
attribution
This file is licensed under the Creative Commons Attribution 4.0 International license.
You are free:
  • to share – to copy, distribute and transmit the work
  • to remix – to adapt the work
Under the following conditions:
  • attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current14:55, 30 January 2021Thumbnail for version as of 14:55, 30 January 20211,800 × 1,230 (159 KB)Guest2625 (talk | contribs)Uploaded a work by Igor de Andrade Santos, Victória Riquena Grosche, Fernando Rodrigues Goulart Bergamini, Robinson Sabino-Silva, and Ana Carolina Gomes Jardim from Santos IA, Grosche VR, Bergamini FRG, Sabino-Silva R and Jardim ACG (2020) Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment? Front. Microbiol. 11:1818. https://doi.org/10.3389/fmicb.2020.01818 with UploadWizard

There are no pages that use this file.

Metadata